Equity Overview
Price & Market Data
Price: $31.19
Daily Change: -$0.57 / 1.83%
Range: $31.19 - $31.98
Market Cap: $0
Volume: 16,524
Performance Metrics
1 Week: 0.86%
1 Month: 10.09%
3 Months: 0.71%
6 Months: -19.12%
1 Year: -7.48%
YTD: -5.57%
Details
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.